OpenAI Launches GPT-Rosalind: Its First Life Sciences AI Model Built to Accelerate Drug Discovery and Genomics Research

OpenAI has launched GPT-Rosalind, its first life sciences model for drug discovery and genomics research.

The model is tuned for biochemistry and genomics tasks and reportedly delivered strong benchmark results.

OpenAI also released a research plugin for Codex that connects to scientific tools and databases.

Access is being rolled out in a controlled way to qualified U.S. enterprise users, with the goal of speeding early research workflows.